Creating a database for ovarian and related cancers
Development of a Prospective and Monocentric Cinical and Biological Database in Epithelial Ovarian Cancer, Fallopian Tube Cancer and Primitive Peritoneal Cancer
This study is creating a detailed database for patients with ovarian and related cancers to help researchers find better treatments and understand the disease more deeply.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT03976999 on ClinicalTrials.gov |
What this trial studies
This project aims to develop a comprehensive clinical and biological database specifically for patients diagnosed with epithelial ovarian cancer, fallopian tube cancer, and primitive peritoneal cancer. The database will include blood and tissue samples along with clinical data to enhance understanding of these cancers and facilitate the development of new treatments. Researchers will utilize this resource to identify predictive factors for treatment responses, prognostic markers, and optimize diagnostic tests. The ultimate goal is to create robust preclinical models for testing alternative therapies and discovering new biomarkers.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 or older who have been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primitive peritoneal cancer and are eligible for surgery and chemotherapy.
Not a fit: Patients who are pregnant, nursing, or unable to participate in regular follow-up due to psychological, familial, social, or geographical reasons may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to improved treatment strategies and outcomes for patients with ovarian and related cancers.
How similar studies have performed: While this approach is not widely tested, similar initiatives in cancer research have shown promise in enhancing treatment development and patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 or older * Patient at the diagnosis of an epithelial ovarian cancer, or a fallopian tube caner or a primitive peritoneal cancer * Patient eligible for, at least, one surgery and a chemotherapy * Patient having given his informed, written and express consent Exclusion Criteria: * Patient not affiliated to a social protection scheme * Pregnant and / or nursing women * Subject under tutelage, curatorship or safeguard of justice * Patient whose regular follow-up is impossible for psychological, familial, social or geographical reasons
Where this trial is running
Montpellier
- ICM - Institut régional du Cancer Montpellier — Montpellier, France (Recruiting)
Study contacts
- Principal investigator: COLOMBO Pierre-Emmanuel, M.D — ICM - Institut régional du Cancer Montpellier
- Study coordinator: Aurore MOUSSION
- Email: DRCI-icm105@icm.unicancer.fr
- Phone: +33 4 67 61 31 02
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.